130 related articles for article (PubMed ID: 3676081)
1. Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage.
Rademaker M; Webb JA; Lowe DG; Meyrick-Thomas RH; Kirby JD; Munro DD
Br J Dermatol; 1987 Sep; 117(3):311-6. PubMed ID: 3676081
[TBL] [Abstract][Full Text] [Related]
2. The value of a baseline liver biopsy prior to methotrexate treatment.
Dolan OM; Burrows D; Irvine A; Walsh M
Br J Dermatol; 1994 Dec; 131(6):891-4. PubMed ID: 7857846
[TBL] [Abstract][Full Text] [Related]
3. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
Ashton RE; Millward-Sadler GH; White JE
J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
[TBL] [Abstract][Full Text] [Related]
4. Liver damage due to methotrexate in patients with psoriasis.
Dahl MG; Gregory MM; Scheuer PJ
Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
[TBL] [Abstract][Full Text] [Related]
5. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
[TBL] [Abstract][Full Text] [Related]
7. Cirrhosis following prolonged treatment of psoriasis with methotrexate orally.
Robeson JA; Spenney J; Hirschowitz BI
South Med J; 1972 Apr; 65(4):453-6. PubMed ID: 5028402
[No Abstract] [Full Text] [Related]
8. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
9. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity.
McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D
Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
Gilbert SC; Klintmalm G; Menter A; Silverman A
Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional abnormalities of the liver in psoriasis before and during methotrexate therapy.
Almeyda J; Barnardo D; Baker H; Levene GM; Landells JW
Br J Dermatol; 1972 Dec; 87(6):623-31. PubMed ID: 4648805
[No Abstract] [Full Text] [Related]
12. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment.
Zachariae H; Kragballe K; Søgaard H
Br J Dermatol; 1980 Apr; 102(4):407-12. PubMed ID: 7387883
[No Abstract] [Full Text] [Related]
13. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
Zachariae H; Grunnet E; Sogaard H
Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
[TBL] [Abstract][Full Text] [Related]
14. Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis.
Nyfors A; Poulsen H
Am J Surg Pathol; 1977 Sep; 1(3):235-43. PubMed ID: 920871
[TBL] [Abstract][Full Text] [Related]
15. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
Nyfors A
Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
[TBL] [Abstract][Full Text] [Related]
16. Natural and Chang liver cell cytotoxic studies of methotrexate-treated psoriatic patients with liver cirrhosis.
Thestrup-Pedersen K; Laurberg G; Søgaard H; Rønnevig JR
Acta Derm Venereol; 1988; 68(1):74-7. PubMed ID: 2449016
[TBL] [Abstract][Full Text] [Related]
17. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
Thomas JA; Aithal GP
Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis caused by methotrexate in the treatment of psoriasis.
Muller SA; Farrow GM; Martalock DL
Arch Dermatol; 1969 Nov; 100(5):523-30. PubMed ID: 5350402
[No Abstract] [Full Text] [Related]
19. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis associated with methotrexate treatment of psoriasis.
Coe RO; Bull FE
JAMA; 1968 Nov; 206(7):1515-20. PubMed ID: 5695945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
